Taiwan Biomaterial Co., Ltd. (TPEX:6649)
Taiwan · Delayed Price · Currency is TWD 49.35
+0.05 (0.10%)
Jan 22, 2026, 1:30 PM CST
Taiwan Biomaterial Market Cap
Taiwan Biomaterial has a market cap or net worth of 2.07 billion as of January 21, 2026. Its market cap has increased by 45.00% in one year.
Market Cap
2.07B
Enterprise Value
1.76B
Revenue
203.27M
Ranking
n/a
PE Ratio
36.51
Stock Price
49.35
Market Cap Chart
Since August 29, 2017, Taiwan Biomaterial's market cap has decreased from 2.34B to 2.07B, a decrease of -11.51%. That is a compound annual growth rate of -1.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.07B | 6.02% |
| Dec 31, 2025 | 1.95B | 35.96% |
| Dec 31, 2024 | 1.44B | 9.27% |
| Dec 29, 2023 | 1.31B | -9.80% |
| Dec 30, 2022 | 1.46B | 78.08% |
| Dec 30, 2021 | 818.40M | -16.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 31.09B |